Contemporary Amperex Technology Co., Limite (3750)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 16 Oct 2026
Key indicators
| Last close | HKD 440.80 |
|---|---|
| 52-week range | 431.00 – 792.55 |
| Return, 1 month / 3 months | −12.0% / −28.6% |
| Return, 1 year / 3 years | −23.0% / – |
| Trend | Below its 200-day average |
| RSI (14) | 24 |
| Volatility (1 year) | 44.7% |
| Worst drawdown (1 year) | -43.3% |
| Average daily value traded | 1,422.29M HKD |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Contemporary Amperex Technology, commonly called CATL, designs and manufactures lithium-ion batteries. Its main products are battery cells and packs for electric passenger cars, buses and trucks, along with battery systems for storing energy on power grids. The company supplies automakers around the world and also works with utilities and industrial customers on energy storage projects. It is based in Ningde, in Fujian province, China, and carries out research and manufacturing there and in other countries.
Contemporary Amperex Technology Co., Limite trades under the code 3750 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Contemporary Amperex Technology Co., Limite (3750) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 440.80 on 16 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 1,692 of 3,157 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.0% and over the last three months it fell 28.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.5% | ||
| From 52-week high | -43.3% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -28.6% | ||
| 6-month return | -38.2% | ||
| 12-month return, skipping the last month | -12.5% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.3% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 1,422.29M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 13 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −10.3% |
|---|---|
| 1 month | −12.0% |
| 3 months | −28.6% |
| 6 months | −38.2% |
| 1 year | −23.0% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 553.44 / 591.53 |
|---|---|
| Golden / death cross (60 days) | Death, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | HKD 1.6290 |
| 10 Apr 2026 | HKD 7.8830 |
| 12 Aug 2025 | HKD 1.1040 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.